5-173235019-T-G

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate

The NM_004387.4(NKX2-5):ā€‹c.65A>Cā€‹(p.Gln22Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000372 in 1,611,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q22K) has been classified as Pathogenic.

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 33)
Exomes š‘“: 0.0000021 ( 0 hom. )

Consequence

NKX2-5
NM_004387.4 missense

Scores

7
9
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 4.74
Variant links:
Genes affected
NKX2-5 (HGNC:2488): (NK2 homeobox 5) This gene encodes a homeobox-containing transcription factor. This transcription factor functions in heart formation and development. Mutations in this gene cause atrial septal defect with atrioventricular conduction defect, and also tetralogy of Fallot, which are both heart malformation diseases. Mutations in this gene can also cause congenital hypothyroidism non-goitrous type 5, a non-autoimmune condition. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr5-173235020-G-T is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.854

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NKX2-5NM_004387.4 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/2 ENST00000329198.5 NP_004378.1 P52952-1A0A0S2Z383
NKX2-5NM_001166176.2 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/2 NP_001159648.1 P52952-2
NKX2-5NM_001166175.2 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/2 NP_001159647.1 P52952-3A0A0S2Z3K2
NKX2-5XM_017009071.3 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/2 XP_016864560.1 E5RH49

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NKX2-5ENST00000329198.5 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/21 NM_004387.4 ENSP00000327758.4 P52952-1
NKX2-5ENST00000424406.2 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/21 ENSP00000395378.2 P52952-3
NKX2-5ENST00000521848.1 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/22 ENSP00000427906.1 P52952-2
NKX2-5ENST00000517440.1 linkuse as main transcriptc.65A>C p.Gln22Pro missense_variant 1/24 ENSP00000429905.1 E5RH49

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000411
AC:
1
AN:
243024
Hom.:
0
AF XY:
0.00000751
AC XY:
1
AN XY:
133092
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1459498
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
726092
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152210
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAiLife Diagnostics, AiLife DiagnosticsJan 18, 2022- -
Uncertain significance, no assertion criteria providedprovider interpretationStanford Center for Inherited Cardiovascular Disease, Stanford UniversityNov 06, 2017p.Gln22Pro ( c.65A>C) in exon 1 of the NKX2-5 gene (NM_004387.3; chr5-172662022-T-G) SCICD Classification: variant of uncertain significance based on limited data to associate this gene with disease, lack of case data and sufficiently rare. We do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). We have seen this variant in a family with arrhythmic cardiomyopathy (DCM/ARVC). Population data: Highest MAF in Latino population: 0.002987% (gnomAD 1/16742). GnomAD overall: 1/119469 individuals. The Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Ashkenazi, Latino descent. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. Another variant at the same codon, p.Gln22Arg has been seen in gnomAD with an MAF of 0.02230% in non-Finnish Europeans (27/60546 individuals). -
Atrial septal defect 7 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMar 03, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects NKX2-5 function (PMID: 17544441). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NKX2-5 protein function. ClinVar contains an entry for this variant (Variation ID: 468245). This missense change has been observed in individual(s) with Tetrology of Fallot (PMID: 14607454). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 22 of the NKX2-5 protein (p.Gln22Pro). -
Tetralogy of Fallot;C1857586:Conotruncal heart malformations;C2673630:Hypothyroidism, congenital, nongoitrous, 5;C3276096:Atrial septal defect 7;C3280785:Ventricular septal defect 3;C3280795:Hypoplastic left heart syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsNov 02, 2021- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 24, 2022The p.Q22P variant (also known as c.65A>C), located in coding exon 1 of the NKX2-5 gene, results from an A to C substitution at nucleotide position 65. The glutamine at codon 22 is replaced by proline, an amino acid with similar properties. This alteration has been reported in a congenital heart disease cohort and one study suggests that this alteration may have an impact on protein function (McElhinney DB et al. J Am Coll Cardiol, 2003 Nov;42:1650-5; Li T et al. J Mol Biol, 2007 Jul;370:976-92). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Pathogenic
0.19
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.82
D;.;.;T
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
D;D;D;D
M_CAP
Pathogenic
0.77
D
MetaRNN
Pathogenic
0.85
D;D;D;D
MetaSVM
Uncertain
0.68
D
MutationAssessor
Benign
1.9
L;L;L;.
PrimateAI
Pathogenic
0.85
D
PROVEAN
Uncertain
-3.4
D;D;D;D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0030
D;D;D;D
Sift4G
Uncertain
0.012
D;D;D;.
Polyphen
0.74
P;.;.;D
Vest4
0.87
MutPred
0.44
Gain of disorder (P = 0.1276);Gain of disorder (P = 0.1276);Gain of disorder (P = 0.1276);Gain of disorder (P = 0.1276);
MVP
0.90
MPC
1.4
ClinPred
0.88
D
GERP RS
2.3
Varity_R
0.75
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201442000; hg19: chr5-172662022; API